Long-term safety and efficacy of axicabtagene ciloleucel (anti-CD19 CAR T) in refractory large B-cell lymphoma: a multicenter, single arm, phase 1–2 trial - Locke, FL; Ghobadi, A; Jacobson, CADB (Lancet Oncol, 2019)